Adhesion, Migration, Transcriptional, Interferon-Inducible, and Other Signaling Molecules Newly Implicated in Cancer Susceptibility and Resistance of JB6 Cells by cDNA Microarray Analyses

Molecular Carcinogenesis

Volumn 39, Issue 1, 2004, Pages 34-60

  Samuel, Shaija ^a   Bernstein, Lori R ^a,b  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Adhesion and migration; Interferon; JB6; Microarray; Transcriptional

Indexed keywords

ACTIN; CELL MARKER; COLLAGEN; COMPLEMENTARY DNA; CYTOSKELETON PROTEIN; DELETED IN ORAL CANCER 1 PROTEIN; GENE PRODUCT; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; HOMEODOMAIN PROTEIN; HOX PROTEIN; INTERFERON; INTERFERON INDUCIBLE PROTEIN 16; MEMBRANE PROTEIN; PHALLOIDIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN PRX2; PROTEINASE; PROTEINASE INHIBITOR; REGULATOR PROTEIN; RETINOIC ACID; S8 HOMEOBOX PROTEIN; SCLEROPROTEIN; SLIT PROTEIN; SLIT2 PROTEIN; TRANSCRIPTION FACTOR CRABP2; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION SUPPRESSOR RIN ZF SP; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CANCER RESISTANCE; CANCER SUSCEPTIBILITY; CELL ADHESION; CELL DAMAGE; CELL LINE; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; GENE FUNCTION; HOMEOBOX; MALIGNANT TRANSFORMATION; MESENCHYME; NERVE FIBER GROWTH; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOGENS; CELL ADHESION; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; INTERFERONS; MICE; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; RNA, NEOPLASM; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 0346727349     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/mc.10163     Document Type: Article

References (277)

1. Colburn NH, Former BF, Nelson KA, Yuspa SH. Tumour promoter induces anchorage independence irreversibly, Nature (London) 1979;281:589-591.
2. Cmarik JL, Min H, Hegameyer G, et al. Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation. Proc Natl Acad Sci USA 1999;96:14037-14042.
3. Bernstein LR, Ben-Ari ET, Simek SL, Colburn NH. Gene regulation and genetic susceptibility to neoplastic transformation: AP-1 and p80 expression in JB6 cells. Environ Health Perspect 1991;93:111-119.
4. Gindhart TD, Nakamura Y, Stevens LA, et al. Genes and signal transduction in tumor promotion: Conclusions from studies with promotion resistant variants of JB6 mouse epidermal cells. In: Mass M, editor. Tumor promotion and enhancement in the etiology of human and experimental respiratory tract carcinogenesis. NY: Ravens Press; 1985. pp 341-368.
5. Angel JM, DiGiovanni J. Genetics of skin tumor promotion. Prog Exp Tumor Res 1999;35:143-157.
6. Bernstein LR, Colburn N. AP1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells. Science 1989;244:566-569.
7. Dong Z, Birrer MJ, Watts RG, Matrisian LM, Colburn NH. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc Natl Acad Sci USA 1994;91:609-613.
8. Li J, Westergaard C, Ghosh P, Colburn NH. Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response. Cancer Res 1997;57:3569-3576.
9. Young MR, Li JJ, Rincon M, et al. Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. Proc Natl Acad Sci USA 1999;96:9827-9832.
10. Sun Y, Hegamyer G, Colburn NH. Molecular cloning of five messenger RNAs differentially expressed in preneoplastic or neoplastic JB6 mouse epidermal cells: One is homologous to human tissue inhibitor of metalloproteinases-3. Cancer Res 1994;54:1139-1144.
11. Bian J, Wang Y, Smith MR, et al. Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP)-3. Carcinogenesis 1996;17:1805-1811.
12. Cmarik JL, Hegamyer G, Gerrard B, Dean M, Colburn NH. cDNA cloning and mapping of mouse pleckstrin (Plek), a gene upregulated in transformation-resistant cells. Genomics 2000;66:204-212.
13. Chen Y, Knosel T, Kristiansen G, et al. Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis. J Pathol 2003;200:640-646.
14. Bernstein LR, Walker SE. Tumor promotion resistant cells are deficient in AP-1 DNA binding, JunD DNA binding, and JunD expression and form different AP-1-DNA complexes than promotion sensitive cells. Biochem Biophys Acta 1999;1489:263-280.
15. Stephens DJ, Banting G. In vivo dynamics of the F-actin-binding protein neurabin-II. Biochem J 2000;345:185-194.
16. Pouliot N, Saunders NA, Kaur P. Laminin 10/11: An alternative adhesive ligand for epidermal keratinocytes with a functional role in promoting proliferation and migration. Exp Dermatol 2002;11:387-397.
17. Dion LD, Bear J, Bateman J, De Luca LM, Colburn NH. Inhibition by tumor-promoting phorbol esters of procollagen synthesis in promotable JB6 mouse epidermal cells. J Natl Cancer Inst 1982;69:1147-1154.
18. Timpl R, Brown JC. Supramolecular assembly of basement membranes. Bioessays 1996;18:123-132.
19. Turner AJ. Cellular peptidases in immune functions and disease 2. In: Langner J, Ansorge K, editors. New York: Academic Plenum Publishers; 2000.
20. Waghray A, Keppler D, Sloane BF, Schuger L, Chen YQ. Analysis of a truncated form of cathepsin H in human prostate tumor cells. J Biol Chem 2002;277:11533-11538.
21. Turk B, Turk D, Turk V. Lysosomal cysteine proteases: More than scavengers. Biochim Biophys Acta 2000;1477:98-111.
22. Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP. Tissue inhibitors of metalloproteinases: Structure, regulation, and biological functions. Eur J Cell Biol 1997;74:111-122.
23. Weber MJ. Inhibition of protease activity in cultures of rous sarcoma virus-transformed cells: Effect on the transformed phenotype. Cell 1975;5:253-261.
24. Bernstein LR, Liotta LA. Molecular mediators of interactions with extracellular matrix components in metastasis and angiogenesis. Curr Opin Oncol 1994;6:106-113.
25. Colandrea TD, D'Armiento J, Kesari KV, Chada KK. Collagenase induction promotes mouse tumorigenesis by two independent pathways. Mol Carcinog 2000;29:8-16.
26. Shoji A, Sakamoto Y, Tsuchiya T, et al. Inhibition of tumor promoter activity toward mouse fibroblasts and their in vitro transformation by tissue inhibitor of metalloproteinases-1 (TIMP-1). Carcinogenesis 1997;18:2093-2100.
27. Sternlicht MD, Lochter A, Sympson CJ, et al. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 1999;98:137-146.
28. Sternlicht MD, Bissell MJ, Werb Z. The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter. Oncogene 2000;19:1102-1113.
29. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001;17:463-516.
30. Chelberg MK, McCarthy JB, Skubitz AP, Furcht LT, Tsilibary EC. Characterization of a synthetic peptide from type IV collagen that promotes melanoma cell adhesion, spreading, and motility. J Cell Biol 1990;111:261-270.
31. Kiefer JA, Farach-Carson MC. Type I collagen-mediated proliferation of PC3 prostate carcinoma cell line: Implications for enhanced growth in the bone microenvironment. Matrix Biol 2001;20:429-437.
32. Sheetz-Jones F, Jones PL. The tenascin family of ECM glycoproteins: Structure, function, and regulation during embryonic development and tissue remodelling. Dev Dynam 2000;218:235-259.
33. Gotz M, Bolz J, Joester A, Faissner A. Tenascin-C synthesis and influence on axonal growth during rat cortical development. Eur J Neurosci 1997;9:496-506.
34. Stander M, Naumann U, Wick W, Weller M. Transforming growth factor-beta and p-21: Multiple molecular targets of decorin-mediated suppression of neoplastic growth. Cell Tissue Res 1999;296:221-227.
35. Merle B, Durussel L, Delmas PD, Clezardin P. Decorin inhibits cell migration through a process requiring its glycosaminoglycan side chain. J Cell Biochem 1999;75:538-546.
36. Kinsella MG, Fischer JW, Mason DP, Wight TN. Retrovirally mediated expression of decorin by macrovascular endothelial cells. Effects on cellular migration and fibronectin fibrillogenesis in vitro. J Biol Chem 2000;275:13924-13932.
37. Hu H. Chemorepulsion of neuronal migration by Slit2 in the developing mammalian forebrain. Neuron 1999;23:703-711.
38. Wu JY, Feng L, Park HT, et al. The neuronal repellent Slit inhibits leukocyte chemotaxis induced by chemotactic factors. Nature 2001;410:948-952.
39. Goshima Y, Ito T, Sasaki Y, Nakamura F. Semaphorins as signals for cell repulsion and invasion. J Clin Invest 2002;109:993-998.
40. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. Molecular biology of the cell, 4th edn. NY: Garland Science Publishing; 2002.
41. Takahashi K, Heine UI, Junker JL, Colburn NH, Rice JM. Role of cytoskeleton changes and expression of the H-ras oncogene during promotion of neoplastic transformation in mouse epidermal JB6 cells. Cancer Res 1986;46:5923-5932.
42. Aoki J, Umeda M, Takio K, et al. Neural cell adhesion molecule mediates contact-dependent inhibition of growth of near-diploid mouse fibroblast cell line m5S/1M. J Cell Blol 1991;15:1751-1761.
43. Kandikonda S, Oda D, Niederman R, Sorkin B. Cadherin-mediated adhesion is required for normal growth regulation of human gingival epithelial cells. Cell Adhes Commun 1996;4:13-24.
44. St. Croix B, Sheehan C, Rak JW, Florenes VA, Slingerland JM, Kerbel RS. E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1). J Cell Biol 1998;142:557-571.
45. Vizirianakis IS, Chen YQ, Kantak SS, Tsiftsoglou AS, Kramer RH. Dominant-negative E-cadherin alters adhesion and reverses contact inhibition of growth in breast carcinoma cell. Int J Oncol 2002;21:135-144.
46. Masuda A, Takenaga K, Kondoh F, Fukami H, Utsumi K, Okayama H. Role of a signal transduction pathway which controls disassembly of microfilament bundles and suppression of high-molecular-weight tropomyosin expression in oncogenic transformation of NRK cells. Oncogene 1996;12:2081-2088.
47. Hynes RO. Integrins: Bidirectional, allosteric signaling machines. Cell 2002;110:673-687.
48. Assoian RK. Anchorage-dependent cell cycle progression. J Cell Biol 1997;136:1-4.
49. Frisch SM, Screaton RA. Anoikis mechanisms. Curr Opin Cell Biol 2001;13:555-562.
50. Fitzgerald DJ, Fusenig NE, Boukamp P, Piccoli C, Mesnil M, Yamasaki H. Expression and function of connexin in normal and transformed human keratinocytes in culture. Carcinogenesis 1994;15:1859-1865.
51. Trosko JE, Ruch RJ. Cell-cell communication in carcinogenesis. Frontiers Biosci 1998;3:208-236.
52. Hirschi KK, Xu C, Tsukamoto T, Sager R. Gapjunction genes Cx26 and Cx43 individually suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential. Cell Growth Differ 1996;7:861-870.
53. Su YA, Bittner ML, Chen Y, et al. Identification of tumor-suppressor genes using human melanoma cell lines UACC903, UACC903(+6), and SRS3 by comparison of expression profiles. Mol Carcinog 2000;28:119-127.
54. King TJ, Fukushima LH, Yasui Y, Lampe PD, Bertram JS. Inducible expression of the gap junction protein connexin43 decreases the neoplastic potential of HT-1080 human fibrosarcoma cells in vitro and in vivo. Mol Carcinog 2002;35:29-41.
55. Hay ED, Zuk A. Transformations between epithelium and mesenchyme: Normal, pathological, and experimentally induced. Am J Kidney Dis 1995;26:678-690.
56. Uberall F, Hellbert K, Kampfer S, et al. Evidence that atypical protein kinase C-lambda and atypical protein kinase C-zeta participate in Ras-mediated reorganization of the F-actin cytoskeleton. J Cell Biol 1999;144:413-425.
57. Maruta H, He H, Tikoo A, Vuong T, Nur-E-Kamal M. G proteins, phosphoinositides, and actincytoskeleton in the control of cancer growth. Microsc Res Tech 1999;47:61-66.
58. 1 phase cell cycle machinery. Bioessays 2000;22:818-826.
59. Kazanietz MG. Eyes wide shut: Protein kinase C isozymes are not the only receptors for the phorbol ester tumor promoters. Mol Carcinog 2000;28:5-11.
60. Huang C, Ma WY, Young MR, Colburn N, Dong Z. Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells. Proc Natl Acad Sci USA 1998;95:156-161.
61. Watts RG, Huang C, Young M, et al. Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation. Oncogene 1998;31:3493-3498.
62. Donovan S, Shannon KM, Bollag G. GTPase activating proteins: Critical regulators of intracellular signaling. Biochim Biophys Acta 2002;1602:23-45.
63. Arlt A, Grobe O, Sieke A, et al. Expression of the NF-kappa B target gene IEX-1 (p22/PRG1) does not prevent cell death but instead triggers apoptosis in HeLa cells. Oncogene 2001;20:69-76.
64. Schilling D, Pittelkow MR, Kumar R. IEX-1, an immediate early gene, increases the rate of apoptosis in keratinocytes. Oncogene 2001;20:7992-7997.
65. Kondratyev AD, Chung K-H, Jung MO. Identification and characterization of a radiation-inducible glycosylated human early-response gene. Cancer Res 1996;56:1498-1502.
66. Kageyama K, Ihara Y, Goto S, et al. Overexpression of calreticulin modulates protein kinase B/Akt signaling to promote apoptosis during cardiac differentiation of cardiomyoblast H9c2 cells. J Biol Chem 2002;277:19255-19264.
67. Nakamura K, Bossy-Wetzel E, Burns K, et al. Changes in endoplasmic reticulum luminal environment affect cell sensitivity to apoptosis. J Cell Biol 2000;150:731-740.
68. Zhu N, Wang Z. Calreticulin expression is associated with androgen regulation of the sensitivity to calcium ionophore-induced apoptosis in LNCaP prostate cancer cells. Cancer Res 1999;59:1896-1902.
69. Winoto A, Littman DR. Nuclear hormone receptors in T lymphocytes. Cell 2002;109:S57-S66.
70. Daigo Y, Suzuki K, Maruyama O, et al. Isolation, mapping, and mutation analysis of a human cDNA homologous to the doc-1 gene of the Chinese hamster, a candidate tumor suppressor for oral cancer. Genes Chromosomes Cancer 1997;20:204-207.
71. Todd R, McBride J, Tsuji T, et al. Deleted in oral cancer-1 (doc-1), a novel oral tumor suppressor gene. FASEB J 1995;9:1362-1370.
72. Johnstone RW, Trapani JA. Transcription and growth regulatory functions of the HIN-200 family of proteins. Mol Cell Biol 1999;19:5833-5838.
73. Dallol A, Da Silva NF, Viacava P, et al. SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers. Cancer Res 2002;62:5874-5880.
74. Dallol A, Morton D, Maher ER, Latif F. SLIT2 axon guidance molecule is frequently inactivated in colorectal cancer and suppresses growth of colorectal carcinoma cells. Cancer Res 2003;63:1054-1058.
75. Saito S, Goto K, Tonosaki A, Kondo H. Gene cloning and characterization of CDP-diacylglycerol synthase from rat brain. J Biol Chem 1997;272:9503-9509.
76. Heacock AM, Agranoff BW. CDP-diacylglycerol synthase from mammalian tissues. Biochim et Biophys Acta 1997;1348:166-172.
77. Lengyel P, Choubey D, Li S-J, Datta B. The interferon-activatable gene 200 cluster: from structure toward function. Semi Virol 1995;6:203-213.
78. Liu CJ, Wang H, Lengyel P. The interferon-inducible nucleolar p204 protein binds the ribosomal RNA-specific UBF1 transcription factor and inhibits ribosomal RNA transcription. EMBO J 1999;18:2845-2854.
79. Johnstone RW, Wei W, Greenway A, Trapani JA. Functional interaction between p53 and the interferon-inducible nucleoprotein IFI 16. Oncogene 2000;19:6033-6042.
80. Tillotson LG. RIN ZF, a novel zinc finger gene, encodes proteins that bind to the CACC element of the gastrin promoter. J Biol Chem 1999;274:8123-8128.
81. Black AR, Black JD, Azizkhan-Clifford J. Spl and kruppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 2001;188:143-160.
82. Altucci L, Gronemeyer H. The promise of retinoids to fight against cancer. Nat Rev Cancer 2001;1:181-193.
83. Budhu AS, Noy N. Direct channeling of retinoic acid between cellular retinoic acid-binding protein II and retinoic acid receptor sensitizes mammary carcinoma cells to retinoic acid-induced growth arrest. Mol Cell Biol 2002;22:2632-2641.
84. Verma AK, Boutwell RK. Vitamin A acid (retinoic acid), a potent inhibitor of 12-O-tetradecanoyl-phorbol-13-acetate-induced ornithine decarboxylase activity in mouse epidermis. Cancer Res 1977;37:2196-2201.
85. Li JJ, Dong Z, Dawson MI, Colburn NH. Inhibition of tumor promoter-induced tansformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element. Cancer Res 1996;56:483-489.
86. Cmarik JL, Herschman H, Colburn NH. Preferential primary-response gene expression in promotion-resistant versus promotion-sensitive JB6 cells. Mol Carcinog 1994;11:115-124.
87. Glass CK. Some new twists in the regulation of gene expression by thyroid hormone and retinoic acid receptors. J Endocrinol 1996;150:349-357.
88. Wu Q, Dawson MI, Zheng Y, et al. Modulation of retinoic acid sensitivity in lung cancer cells through dynamic balance of orphan receptors nur77 and COUP-TF and their heterodimerization. Mol Cell Biol 1997;17:6598-6608.
89. Wu Q, Liu S, Ye XF, Huang ZW, Su WJ. Dual roles of Nur77 in selective regulation of apoptosis and cell cycle by TPA and ATRA in gastric cancer cells. Carcinogenesis 2002;23:1583-1592.
90. Dong D, Ruuska SE, Levinthal DJ, Noy N. Distinct roles for cellular retinoic acid-binding proteins I and II in regulating signaling by retinoic acid. J Biol Chem 1999;274:23695-23698.
91. Delva L, Bastie JN, Rochette-Egly C, et al. Physical and functional interactions between cellular retinoic acid binding protein II and the retinoic acid-dependent nuclear complex. Mol Cell Biol 1999;19:7158-7167.
92. Krause K-H, Michalak M. Calreticulin. Cell 1997;88:439-443.
93. Kongsuwan K, Webb E, Housiaux P, Adams JM. Expression of multiple homeobox genes within diverse mammalian haemopoietic lineages. EMBO J 1988;7:2131-2138.
94. de Jong R, Meijlink F. The homeobox gene S8: Mesoderm-specific expression in presomite embryos and in cells cultured in vitro and modulation in differentiating pluripotent cells. Dev Biol 1993;157:133-146.
95. Norris RA, Kern MJ. Identification of domains mediating transcription activation, repression, and inhibition in the paired-related homeobox protein, Prx2 (S8). DNA Cell Biol 2001;20:89-99.
96. Dhar A, Young MR, Colburn NH. The role of AP-1, NF-kappaB, and ROS/NOS in skin carcinogenesis: The JB6 model is predictive. Mol Cell Biochem 2002;234-235:185-193.
97. Ben-Ari ET, Bernstein LR, Colburn NH. Differential c-jun expression in response to tumor promoters in JB6 cells sensitive or resistant to neoplastic transformation. Mol Carcinog 1992;5:62-74.
98. Kiefer JA, Farach-Carson MC. Type I collagen-mediated proliferation of PC3 prostate carcinoma cell line: Implications for enhanced growth in the bone microenvironment. Matrix Biol 2001;20:429-437.
99. Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM. Matrix metalloproteinases: Biologic activity and clinical implications. J Clin Oncol 2000;18:1135-1149.
100. Inagaki Y, Truter S, Ramirez F. Transforming growth factor-beta stimulates alpha 2(I) collagen gene expression through a cis-acting element that contains an Sp1-binding site. J Biol Chem 1994;269:14828-14834.
101. Luparello C, Sheterline P, Pucci-Minafra I, Minafra S. A comparison of spreading and motility behaviour of 8701-BC breast carcinoma cells on type I, I-trimer and type V collagen substrata. Evidence for a permissive effect of type I-trimer collagen on cell locomotion. J Cell Science 1991;100:179-185.
102. Zeisberg M, Bonner G, Maeshima Y, et al. Renal fibrosis: Collagen composition and assembly regulates epithelial-mesenchymal transdifferentiation. Am J Pathol 2001;159:1313.
103. Birk DE. Type V collagen: Heterotypic type I/V collagen interactions in the regulation of fibril assembly. Micron 2001;32:223-237.
104. Kagan HM. Intra- and extra-cellular enzymes of collagen biosynthesis as biological and chemical targets in the control of fibrosis. Acta Trop 2000;77:147-152.
105. Lazarus HM, Cruikshank WW, Narasimhan N, Kagan HM, Center DM. Induction of human monocyte motility by lysyl oxidase. Matrix Biol 1995;14:727-731.
106. Csiszar K. Lysyl oxidases: A novel multifunctional amine oxidase family. Prog Nucleic Acids Res 2001;70:1-32.
107. Keene DR, Engvall E, Glanville RW. Ultrastructure of type VI collagen in human skin and cartilage suggests an anchoring function for this filamentous network. J Cell Biol 1988;107:1995-2006.
108. Kielty CM, Lees M, Shuttleworth CA, Woolley D. Catabolism of intact type VI collagen microfibrils: Susceptibility to degradation by serine proteinases. Biochem Biophys Res Commun 1993;191:1230-1236.
109. Loeser RF. Growth factor regulation of chondrocyte integrins. Differential effects of insulin-like growth factor 1 and transforming growth factor beta on alpha 1 beta 1 integrin expression and chondrocyte adhesion to type VI collagen. Arthritis Rheum 1997;40:270-276.
110. Burg MA, Nishiyama A, Stallcup WB. A central segment of the NG2 proteoglycan is critical for the ability of glioma cells to bind and migrate toward type VI collagen. Exp Cell Res 1997;235:254-264.
111. Davis G E, Bayless KJ, Davis MJ, Meininger GA. Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules. Am J Pathol 2000;156:1489-1498.
112. Timpl R, Brown JC. Supramolecular assembly of basement membranes. Bioessays 1996;18:123-132.
113. Yelian FD, Edgeworth NA, Dong LJ, Chung JE, Armant DR. Recombinant entactin promotes mouse primary trophoblast cell adhesion and migration through the Arg-Gly-Asp (RGD) recognition sequence. J Cell Biol 1993;121:923-929.
114. Senior RM, Gresham HD, Brown EJ, Chung AE. Entactin stimulates neutrophil adhesion and chemotaxis through interactions between its Arg-Gly-Asp (RGD) domain and the leukocyte response integrin. J Clin Invest 1992;90:2251-2257.
115. Song W, Jackson K, McGuire P. Degradation of type IV collagen by matrix metalloproteinases is an important step in the epithelial-mesenchymal transformation of the endocardial cushions. Dev Biol 2000;227:606-617.
116. Koga N, Shin'yama A, Ishida C, Hanioka N, Yoshimura H. A new metabolite of 2,4,3′,4′-tetrachlorobiphenyl in rat feces. Chem Pharm Bull (Tokyo) 1992;40:3338-3339.
117. Waghray A, Keppler D, Sloane BF, Schuger L, Chen YQ. Analysis of a truncated form of cathepsin H in human prostate tumor cells. J Biol Chem 2002;277:11533-11538.
118. Turk B, Turk D, Turk V. Lysosomal cysteine proteases: More than scavengers. Biochim Biophys Acta 2000;1477:98-111.
119. Taipale J, Kaeski-Oja J. Growth factors in the extracellular matrix. FASEB J 1997;11:51-59.
120. Colburn NH, Gindhart TD, Hegameyer GA, et al. Phorbol diester and epidermal growth factor receptors in 12-O-tetradecanoylphorbol-13-acetate-resistant and -sensitive mouse epidermal cells. J Cancer Res 1982;42:3093-3097.
121. Wilder PJ, Rizzino A. Effects of transforming growth factor beta on the anchorage-independent growth of murine epithelial JB6 cells. Cancer Res 1991;51:5898-5902.
122. Turner AJ, Brown CD, Carson JA, Barnes K. The neprilysin family in health and disease. Adv Exp Med Biol 2000;477:229-240.
123. Woessner JF, Nagase H. Matrix metalloproteinases and TIMPS. New York: Oxford University Press; 2000.
124. Jiang Y, Goldberg ID, Shi YE. Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene 2002;21:2245-2252.
125. Eisenberg SP, Hale KK, Heimda LP, Thompson RC. Location of the protease-inhibitory region of secretory leukocyte protease inhibitor. J Biol Chem 1990;265:7976-7981.
126. Zitnik RJ, Zhang J, Kashem MA, et al. The cloning and characterization of a murine secretory leukocyte protease inhibitor cDNA. Biochem Biophys Res Commun 1997;232:687-697.
127. Zhang Y, DeWitt DL, McNeely TB, Wahl SM, Wahl LM. Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin Hsynthase-2, prostaglandin E2, and matrix metalloproteinases. J Clin Invest 1997;99:894-900.
128. Hiemstra PS, Kramps JA, deVreede TM, Breedveld FC, Daha MR. Inhibition of polymorphonuclear leukocyte-mediated endothelial cell detachment by antileukoprotease: a comparison with other proteinase inhibitors. Immunobiology 1991;182:117-126.
129. Lentsch AB, Jordan JA, Czermak BJ, et al. Inhibition of NF-kappaB activation and augmentation of IkappaBbeta by secretory leukocyte protease inhibitor during lung inflammation. Am J Pathol 1999;154:239-247.
130. Li JJ, Cao Y, Young MR, Colburn NH. Induced expression of dominant-negative c-jun downregulates NFkappaB and AP-1 target genes and suppresses tumor phenotype in human keratinocytes. Mol Cacinog 2000;29:159-169.
131. Stander M, Naumann U, Wick W, Weller M. Transforming growth factor-beta and p-21: Multiple molecular targets of decorin-mediated suppression of neoplastic growth. Cell Tissue Res 1999;296:221-227.
132. Toole BP, Lowther DA. Dermatan sulfate-protein: Isolation from and interaction with collagen. Arch Biochem Biophys 1968;128:567-578.
133. Toole BP, Lowther DA. The effect of chondroitin sulphate-protein on the formation of collagen fibrils in vitro. Biochem J 1968;109:857-866.
134. Grant DS, Yenisey C, Rose RW, Tootell M, Santra M, Iozzo R. Decorin suppresses tumor cell-mediated angiogenesis. Oncogene 2002;21:4765-4777.
135. Winnemoller M, Schin P, Vischer P, Kresse H. Interactions between thrombospondin and the small proteoglycan decorin: Interference with cell attachment. Eur J Cell Biol 1992;59:47-55.
136. Yamaguchi Y, Mann DM, Ruoslahti E. Negative regulation of transforming growth factor beta by the proteoglycan decorin. Nature 1990;346:281-284.
137. Santra M, Eichstetter I, Iozzo RV. An anti-oncogenic role for decorin. Down-regulation of ErbB2 leads to growth suppression and cytodifferentiation of mammary carcinoma cells. J Biol Chem 2000;275:35153-35161.
138. De Luca A, Santra M, Baldi A, Giordano A, Iozzo RV. Decorin-induced growth suppression is associated with upregulation of p21, an inhibitor of cyclin-dependent kinases. J Biol Chem 1996;271:18961-18965.
139. Merle B, Durussel L, Delmas PD, Clezardin P. Decorin inhibits cell migration through a process requiring its glycosaminoglycan side chain. J Cell Biochem 1999;75:538-546.
140. Kinsella MG, Fischer JW, Mason DP, Wight TN. Retrovirally mediated expression of decorin by macrovascular endothelial cells. Effects on cellular migration and fibronectin fibrillogenesis in vitro. J Biol Chem 2000;275:13924-13932.
141. Kresse H, Schonherr E. Proteoglycans of the extracellular matrix and growth control. J Cell Physiol 2001;189:266-274.
142. Wu Y, Chen L, Zheng PS, Yang BB. Beta 1-integrin-mediated glioma cell adhesion and free radical-induced apoptosis are regulated by binding to a C-terminal domain of PG-M/versican. J Biol Chem 2002;277:12294-12301.
143. 1 domain of versican. J Cell Biochem 1999;72:210-220.
144. Perris R, Perissinotto D, Pettway Z, Broner-Frazer M, Morgelin M, Kimata K. Inhibitory effects of PG-H/aggrecan and PG-M/versican on avian neural crest cell migration. FASEB J 1996;10:293-301.
145. Landolt RM, Vaughan L, Winterhalter KH, Zimmermann DR. Versican is selectively expressed in embryonic tissues that act as barriers to neural crest cell migration and axon outgrowth. Development 1995;121:2303-2312.
146. Hoffman S, Crossin KL, Edelman GM. Molecular forms, binding functions, and developmental expression patterns of cytotactin and cytotactin-binding proteoglycan, an interactive pair of extracellular matrix molecules. J Cell Biol 1988;106:519-532.
147. Jones FS, Jones PL. The tenascin family of ECM glycoproteins: Structure, function, and regulation during embryonic development and tissue remodelling. Dev Dyn 2000;218:235-259.
148. Sheetz-jones F, Jones PL. The tenascin family of ECM glycoproteins: Structure, function, and regulation during embryonic development and tissue remodelling. Dev Dyn 2000;218:235-259.
149. Spring J, Beck K, Chiquet-Ehrismann R. Two contrary functions of tenascin: Dissection of the active sites by recombinant tenascin fragments. Cell 1989;59:325-334.
150. Gotz M, Bolz J, Joester A, Faissner A. Tenascin-C synthesis and influence on axonal growth during rat cortical development. Eur J Neurosci 1997;9:496-506.
151. Jones PL, Jones FS. Tenascin C in development and disease: Gene regulation and cell function. Matrix Biol 2000;19:581-596.
152. Dandachi N, Hauser-Kronberger C, More E, et al. Coexpression of tenascin-C and vimentin in human breast cancer cells indicates phenotypic transdifferentiation during tumor progression: Correlation with histopathological parameters, hormone receptors, and oncoproteins. J Pathol 2001;193:181-189.
153. Taguchi A, Wanaka A, Mori T, et al. Molecular cloning of novel leucine-rich repeat proteins and their expression in the developing mouse nervous system. Brain Res Mol Brain Res 1996;35:31-40.
154. Yuan W, Zhou L, Chen JH, Wu JY, Rao Y, Ornitz DM. The mouse SLiT family: Secreted ligands for ROBO expressed in patterns that suggest a role in morphogenesis and axon guidance. Dev Biol 1999;212:290-306.
155. Hu H. Chemorepulsion of neuronal migration by Slit2 in the developing mammalian forebrain. Neuron 1999;23:703-711.
156. Dallol A, Da Silva NF, Viacava P, et al. SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers. Cancer Res 2002;62:5874-5880.
157. Dallol A, Morton D, Maher ER, Latif F. SLIT2 axon guidance molecule is frequently inactivated in colorectal cancer and suppresses growth of colorectal carcinoma cells. Cancer Res 2003;63:1054-1058.
158. Goshima Y, Ito T, Sasaki Y, Nakamura F. Semaphorins as signals for cell repulsion and invasion. J Clin Invest 2002;109:993-998.
159. Kolodkin AL, Levengood DV, Rowe EG, Tai YT, Giger RJ, Ginty DD. Neuropilin is a semaphorin III receptor. Cell 1997;90:753-762.
160. Miao HQ, Soker S, Feiner L, Alonso JL, Raper JA, Klagsburn M. Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: Functional competition of collapsin-1 and vascular endothelial growth factor-165. J Cell Biol 1999;146:233-242.
161. Zou Y, Stoeckli E, Chen H, Tessier-Lavigne M. Squeezing axons out of the gray matter: A role for slit and semaphorin proteins from midline and ventral spinal cord. Cell 2000;102:363-375.
162. Lucas AD, Chadwick N, Warren BF, et al. The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo. Am J Pathol 2001;158:855-866.
163. Kansra V, Groves C, Gutierrez-Ramos JC, Polakiewicz RD. Phosphatidylinositol 3-kinase-dependent extracellular calcium influx is essential for CX(3)CR1-mediated activation of the mitogen-activated protein kinase cascade. J Biol Chem 2001;276:31831-31838.
164. Faure S, Meyer L, Costagliola D, et al. Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1. Science 2000;287:2274-2277.
165. Brand S, Sakaguchi T, Gu X, Colgan SP, Reinecker HC. Fractalkine-mediated signals regulate cell-survival and immune-modulatory responses in intestinal epithelial cells. Gastroenterology 2002;122:166-177.
166. Dichmann S, Herouy Y, Purlis D, Rheinen H, Gebicke-Harter P, Norgauer J. Fractalkine induces chemotaxis and actin polymerization in human dendritic cells. Inflamm Res 2001;50:529-533.
167. Naeve GS, Ramakrishnan M, Kramer R, Hevroni D, Citri Y, Theill LE. Neuritin: A gene induced by neural activity and neurotrophins that promotes neuritogenesis. Proc Natl Acad Sci USA 1997;94:2648-2653.
168. Araki T, Milbrandt J. Ninjurin, a novel adhesion molecule, is induced by nerve injury and promotes axonal growth. J Neuron 1996;17:353-361.
169. Araki T, Zimonjic DB, Popescu NC, Milbrandt J. Mechanism of homophilic binding mediated by ninjurin, a novel widely expressed adhesion molecule. J Biol Chem 1997;272:21373-21380.
170. Price PA, Urist MR, Otawara Y. Matrix Gla protein, a new gamma-carboxyglutamic acid containing protein which is associated with the organic matrix of bone. Biochem Biophys Res Commun 1983;117:765-771.
171. Price PA, Otsuka AA, Poser JW, Kristaponis J, Raman N. Characterization of a gamma-carboxyglutamic acid-containing protein from bone. Proc Natl Acad Sci USA 1976;73:1447-1451.
172. Otawara Y, Price PA. Developmental appearance of matrix GLA protein during calcification in the rat. J Biol Chem 1986;261:10828-10832.
173. Shearer MJ. Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification. Curr Opin Clin Nutr Metab Care 2000;3:433-438.
174. Chen L, O'Bryan JP, Smith HS, Liu E. Overexpression of matrix Gla protein mRNA in malignant human breast cells: Isolation by differential cDNA hybridization. Oncogene 1990;5:1391-1395.
175. Levedakou EN, Strohmeyer TG, Effert PJ, Liu ET. Expression of the matrix Gla protein in urogenital malignancies. Int J Cancer 1992;52:534-537.
176. North AJ, Gimona M, Cross RA, Small JV. Calponin is localised in both the contractile apparatus and the cytoskeleton of smooth muscle cells. J Cell
177. el-Mezgueldi M. Calponin. Int J Biochem Cell Biol 1996;28:1185-1189.
178. Galmiche MC, Koteliansky VE, Briere J, Herve P, Charbord P. Stromal cells from human long-term marrow cultures are mesenchymal cells that differentiate following a vascular smooth muscle differentiation pathway. Blood 1993;83:66-76.
179. Lazard D, Sastre X, Frid MG, Glukhova MA, Thiery JP, Koteliansky VE. Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue. Proc Natl Acad Sci USA 1993;90:999-1003.
180. Ferrari S, Calabretta B, deRiel JK, et al. Structural and functional analysis of a growth-regulated gene, the human calcyclin. J Biol Chem 1987;262:8325-8332.
181. Weterman MA, van Muijen GN, Bloemers HP, Ruiter DJ. Expression of calcyclin in human melanocytic lesions. Cancer Res 1993;53:6061-6066.
182. Camby I, Nagy N, Lopes MB, et al. Supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas, and glioblastomas are characterized by a differential expression of S100 proteins. Brain Pathol 1999;9:825-843.
183. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. Molecular biology of cell, 4th edn. New York: Garland Science, Taylor and Francis group; 2002.
184. Zanellato AM, Borrione AC, Saggin L, Giuriato L, Schiaffino S, Sartore S. Troponin T- and troponin I-like proteins in bovine vascular smooth muscle. Circ Res 1991;68:1349-1361.
185. Khaitlina SY. Functional specificity of actin isoforms. Int Rev Cytol 2001;202:35-98.
186. Strutz F, Zeisberg M, Ziyadeh FN, et al. Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. Kidney Int 2002;61:1714-1728.
187. Kobayashi R, Kobuta T, Hidaka H. Purification, characterization, and partial sequence analysis of a new 25-kDa actin-binding protein from bovine aorta: A SM22 homolog. Biochem Biophys Res Commun 1994;198:1275-1280.
188. Zhang JC, Helmke BP, Shum A, et al. SM22beta encodes a lineage-restricted cytoskeletal protein with a unique developmentally regulated pattern of expression. Mech Dev 2002;115:161-166.
189. Morgan KG, Gangopadhyay SS. Invited review: Cross-bridge regulation by thin filament-associated proteins. J Appl Physiol 2001;91:953-962.
190. Huot J, Houle F, Rousseau S, Deschesnes RG, Shah GM, Landry J. SAPK2/p38-dependent F-actin reorganization regulates early membrane blebbing during stress-induced apoptosis. J Cell Biol 1998;143:1361-1373.
191. Beckerle MC. Zyxin: Zinc fingers at sites of cell adhesion. Bioessays 1997;19:949-957.
192. van der Gaag EJ, Leccia MT, Dekker SK, Jalbert NL, Amodeo DM, Byers HR. Role of zyxin in differential cell spreading and proliferation of melanoma cells and melanocytes. J Invest Dermatol 2002;118:246-254.
193. Fradelizi J, Noireaux V, Plastino J, et al. Acta and human zyxin harbour Arp2/3-independent actin-polymerization activity. Nat Cell Biol 2001;3:699-707.
194. Nix DA, Fradelizi J, Bockholt S, et al. Targeting of zyxin to sites of actin membrane interaction and to the nucleus. J Biol Chem 2001;276:34759-34767.
195. Adler HJ, Winnicki RS, Gong TW, Lomax MI. A gene upregulated in the acoustically damaged chick basilar papilla encodes a novel WD40 repeat protein. Genomics 1999;56:59-69.
196. Bamburg JR, McGough A, Ono S. Putting a new twist on actin: ADF/cofilins modulate actin dynamics. Trends Cell Biol 1999;9:364-370.
197. Bamburg JR. Proteins of the ADF/cofilin family: Essential regulators of actin dynamics. Ann Rev Cell Dev Biol 1999;15:185-230.
198. Yahara I, Aizawa H, Moriyama K, et al. Role of cofilin/destrin in reorganization of actin cytoskeleton in response to stresses and cell stimuli. Cell Struct Funct 1996;21:421-424.
199. Saito T, Lamy F, Roger PP, Lecocq R, Dumont JE. Characterization and identification as cofilin and destrin of two thyrotropin- and phorbol ester-regulated phosphoproteins in thyroid cells. Exp Cell Res 1994;212:49-61.
200. Leung CL, Sun D, Zheng M, Knowles DR, Liem RK. Microtubule actin cross-linking factor (MACF): A hybrid of dystonin and dystrophin that can interact with the act in and microtubule cytoskeletons. J Cell Biol 1999;147:1275-1285.
201. Leung CL, Green KJ, Liem RK. Plakins: A family of versatile cytolinker proteins. Trends Cell Biol 2000;12:37-45.
202. Pawlak G, Helfman DM. Cytoskeletal changes in cell transformation and tumorigenesis. Curr Opin in Genet Dev 2001;11:41-47.
203. Boguski MS, McCormack F. Proteins regulating Ras and its relatives. Nature 1993;366:643-654.
204. Avruch J, Khokhlatchev A, Kyriakis JM. et al. Ras activation of the Raf kinase: Tyrosine kinase recruitment of the MAP kinase cascade. Recent Prog Horm Res 2001;56:127-155.
205. Uberall F, Hellbert K, Kampfer S, et al. Evidence that atypical protein kinase C-lambda and atypical protein kinase C-zeta participate in Ras-mediated reorganization of the F-actin cytoskeleton. J Cell Biol 1999;144:413-425.
206. Maruta H, He H, Tikoo A, Vuong T, Nur-E-Kamal M. G proteins, phosphoinositides, and actin-cytoskeleton in the control of cancer growth. Microsc Res Tech 1999;47:61-66.
207. Hay ED, Zuk A. Transformations between epithelium and mesenchyme: Normal, pathological, and experimentally induced. Am J Kidney Dis 1995;26:678-690.
208. Wittinghofer A. Signal transduction via Ras. Biol Chem 1998;379:933-937.
209. Kulkarni SV, Gish G, van der Geer P, Henkemeyer M, Pawson T. Role of p120 Ras-GAP in directed cell movement. J Cell Biol 2000;149:457-470.
210. Dijke PT, Gouman M-J, Itoh F. Regulation of cell proliferation by Smad proteins. J Cell Physiol 2002;191:1-16.
211. Jin Y, Tipoe GL, Liong EC, Lau TY, Fung PC, Leung KM. Overexpression of BMP-2/4, -5, and BMPR-IA associated with malignancy of oral epithelium. Oral Oncol 2001;37:225-233.
212. Beck HN, Drahushuk K, Jacoby DB, Higgins D, Lein PJ. Bone morphogenetic protein-5 (BMP-5) promotes dendritic growth in cultured sympathetic neurons. BMC Neurosci 2001;2:12-22.
213. Miyazono K, Kusanagi K, Inoue H. Divergence and convergence of TGF-beta/BMP signaling. J Cell Physiol 2001;187:265-276.
214. Vaandrager AB, Ehlert EM, Jarchau T, Lohmann SM, de Jonge HR. N-terminal myristoylation is required for membrane localization of cGMP-dependent protein kinase type II. J Biol Chem 1996;271:7025-7029.
215. Chiang TM. Okadaic acid and vanadate inhibit collagen-induced platelet aggregation; the functional relation of phosphatases on platelet aggregation. Thromb Res 1992;67:345-354.
216. Strunck E, Frank K, Tan MI, Vollmer G. Expression of L-3-phosphoserine phosphatase is regulated by reconstituted basement membrane. Biochem Biophys Res Commun 2001;281:747-753.
217. Bosma PJ, Seppen J, Goldhoorn B, et al. Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. J Biol Chem 1994;269:17960-17964.
218. Bosma PJ, Chowdhury JR, Bakker C, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyl-transferase 1 in Gilbert's syndrome. N Engl J Med 1995;333:1171-1175.
219. Radominska A, Little JM, Lehman PA, et al. Glucuronidation of retinoids by rat recombinant UDP: Glucuronosyltransferase 1.1 (bilirubin UGT). Drug Metab Dispos 1997;25:889-892.
220. Lohmann SM, Vaandrager AB, Smolenski A, Walter U, Jonge De. Distinct and specific functions of cGMP-dependent protein kinases. Trends Biochem Sci 1997;22:307-312.
221. Saito S, Goto K, Tonosaki A, Kondo H. Gene cloning and characterization of CDP-diacylglycerol synthase from rat brain. J Biol Chem 1997;272:9503-9509.
222. Heacock AM, Agranoff BW. CDP-diacylglycerol synthase from mammalian tissues. Biochim et Biophys Acta 1997;1348:166-172.
223. Kazanietz MG. Eyes wide shut: Protein kinase C isozymes are not the only receptors for the phorbol ester tumor promoters. Mol Carcinog 2000;28:5-11.
224. Willnow TE. The low-density lipoprotein receptor gene family: Multiple roles in lipid metabolism. J Mol Med 1999;77:306-315.
225. Webb DJ, Nguyen DH, Sankovic M, Gonias SL. The very low density lipoprotein receptor regulates urokinase receptor catabolism and breast cancer cell motility in vitro. J Biol Chem 1999;274:7412-7420.
226. Watts RG, Huang C, Young M, et al. Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation. Oncogene 1998;31:3493-3498.
227. Huang C, Ma WY, Young MR, Colburn N, Dong Z. Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells. Proc Natl Acad Sci USA 1998;95:156-161.
228. 2+ channels: Role in channel function. Trends Neurosci 1998;21:148-154.
229. Murphy HS, Maroughi M, Till GO, Ward PA. Phorbol-stimulated influx of extracellular calcium in rat pulmonary artery endothelial cells. Am J Physiol 1994;267:145-151.
230. Asem EK, Qin W, Rane SG. Effect of basal lamina of ovarian follicle on T- and L-type Ca(2+) currents in differentiated granulosa cells. Am J Physiol Endocrinol Metab 2002;282:184-196.
231. Coppolino MG, Dedhar S. Calreticulin. Int J Biochem Cell Biol 1998;30:553-558.
232. Michalak M, Corbett EF, Mesaeli N, Nakamura K, Opas M. Calreticulin: One protein, one gene, many functions. Biochem J 1994;344:281-292.
233. Johnson S, Michalak M, Opas M, Eggleton P. The ins and outs of calreticulin: From the ER lumen to the extracellular space. Trends Cell Biol 2001;11:122-129.
234. Krause K-H, Michalak M. Calreticulin. Cell 1997;88:439-443.
235. Todd R, McBride J, Tsuji T, et al. Deleted in oral cancer-1 (doc-1), a novel oral tumor suppressor gene. FASEB J 1995;9:1362-1370.
236. Tsuji T, Duh FM, Latif F, et al. Cloning, mapping, expression, function, and mutation analyses of the human ortholog of the hamster putative tumor suppressor gene Doc-1. J Biol Chem 1998;273:6704-6709.
237. Shintani S, Mihara M, Nakahara Y, et al. Expression of cell cycle control proteins in normal epithelium, premalignant, and malignant lesions of oral cavity. Oral Oncol 2001;38:235-243.
238. Kondratyev AD, Chung K-H, Jung MO. Identification and characterization of a radiation-inducible glycosylated human early-response gene. Cancer Res 1996;56:1498-1502.
239. Kobayashi TK, Pittelkow MR, Warner GM, Squillance KA, Kumar R. Regulation of a novel immediate early response gene, IEX-1, in keratinocytes by 1alpha,25-dihydroxyvitamin D3. Biochim Biophys Res Comm 1998;251:868-873.
240. Arlt A, Grobe O, Sieke A, et al. Expression of the NF-kappa B target gene IEX-1 (p22/PRG1) does not prevent cell death but instead triggers apoptosis in HeLa cells. Oncogene 2001;20:69-76.
241. Schilling D, Pittelkow MR, Kumar R. IEX-1, an immediate early gene, increases the rate of apoptosis in keratinocytes. Oncogene 2001;20:7992-7997.
242. Trosko JE, Ruch RJ. Cell-cell communication in carcinogenesis. Frontiers Biosci 1998;3:208-236.
243. Fitzgerald DJ, Fusenig NE, Boukamp P, Piccoli C, Mesnil M, Yamasaki H. Expression and function of connexin in normal and transformed human keratinocytes in culture. Carcinogenesis 1994;15:1859-1865.
244. Hirschi KK, Xu C, Tsukamoto T, Sager R. Gap junction genes Cx26 and Cx43 individually suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential. Cell Growth Differ 1996;7:861-870.
245. Su YA, Bittner ML, Chen Y, et al. Identification of tumor-suppressor genes using human melanoma cell lines UACC903, UACC903(+6), and SRS3 by comparison of expression profiles. Mol Carcinog 2000;28:119-127.
246. King TJ, Fukushima LH, Yasui Y, Lampe PD, Bertram JS. Inducible expression of the gap junction protein connexin43 decreases the neoplastic potential of HT-1080 human fibrosarcoma cells in vitro and in vivo. Mol Carcinog 2002;35:29-41.
247. Budunova IV, Carbajal S, Viaje A, Slaga TJ. Connexin expression in epidermal cell lines from SENCAR mouse skin tumors. Mol Carcinog 1996;15:190-201.
248. Sawey MJ, Goldschmidt MH, Risek B, Gilula NB, Lo CW. Perturbation in connexin 43 and connexin 26 gap-junction expression in mouse skin hyperplasia and neoplasia. Mol Carcinog 1996;17:49-61.
249. Hossain MZ, Ao P, Boynton AL. Platelet-derived growth factor-induced disruption of gap junctional communication and phosphorylation of connexin43 involves protein kinase C and mitogen-activated protein kinase. J Cell Physiol 1998;176:332-341.
250. Lin JH, Takano T, Cotrina ML, et al. Connexin 43 enhances the adhesivity and mediates the invasion of malignant glioma cells. J Neurosci 2002;22:4302-4311.
251. Gribaudo G, Ravaglia S, Guanalini L, Riera L, Landolfo S. Molecular cloning and expression of an interferon-inducible protein encoded by gene 203 from the gene 200 cluster. Eur J Biochem 1997;249:258-264.
252. Johnstone RW, Trapani JA. Transcription and growth regulatory functions of the HIN-200 family of proteins. Mol Cell Biol 1999;19:5833-5838.
253. Johnstone RW, Wei W, Greenway A, Trapani JA. Functional interaction between p53 and the interferon-inducible nucleoprotein IFI 16. Oncogene 2000;19:6033-6042.
254. Tillotson LG. RIN ZF, a novel zinc finger gene, encodes proteins that bind to the CACC element of the gastrin promoter. J Biol Chem 1999;274:8123-8128.
255. Black AR, Black JD, Azizkhan-Clifford J. Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 2001;188:143-160.
256. Hazel TG, Nathans D, Lau LF. A gene inducible by serum growth factors encodes a member of the steroid and thyroid hormone receptor superfamily. Proc Natl Acad Sci USA 1988;85:8444-8448.
257. Woronicz JD, Calnan B, Ngo V, Winoto A. Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas, Nature 1994;367:277-281.
258. Ryseck RP, Macdonald-Bravo H, Mattei MG, Ruppert S, Bravo R. Structure, mapping, and expression of a growth factor inducible gene encoding a putative nuclear hormonal binding receptor. EMBO J 1989;8:3327-3335.
259. Verma AK, Boutwell RK. Vitamin A acid (retinoic acid), a potent inhibitor of 12-O-tetradecanoyl-phorbol-13-acetate-induced ornithine decarboxylase activity in mouse epidermis. Cancer Res 1977;37:2196-2201.
260. Li JJ, Dong Z, Dawson MI, Colburn NH. Inhibition of tumor promoter-induced tansformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element. Cancer Res 1996;56:483-489.
261. Perlmann T, Jansson L. A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1. Genes Dev 1995;9:769-782.
262. Wu Q, Li Y, Liu R, et al. Modulation of retinoic acid sensitivity in lung cancer cells through dynamic balance of orphan receptors nur77 and COUP-TF and their heterodimerization. EMBO J 1997;16:1656-1669.
263. Dong D, Ruuska SE, Levinthal DJ, Noy N. Distinct roles for cellular retinoic acid-binding proteins I and II in regulating signaling by retinoic acid. J Biol Chem 1999;274:23695-23698.
264. Wolf G. Cellular retinoic acid-binding protein II: A coactivator of the transactivation by the retinoic acid receptor complex RAR.RXR. Nutr Rev 2000;58:151-153.
265. Kongsuwan K, Webb E, Housiaux P, Adams J. Expression of multiple homeobox genes within diverse mammalian haemopoietic lineages. EMBO J 1988;7:2131-2138.
266. Norris RA, Kern MJ. Identification of domains mediating transcription activation, repression, and inhibition in the paired-related homeobox protein, Prx2 (S8). DNA Cell Biol 2001;20:89-99.
267. de Jong R, van der Heijden J, Meijlink F. DNA-binding specificity of the S8 homeodomain. Nucleic Acids Res 1993;21:4711-4720.
268. Dresios J, Derkatch IL, Liebman SW, Synetos D. Yeast ribosomal protein L24 affects the kinetics of protein synthesis and ribosomal protein L39 improves translational accuracy, while mutants lacking both remain viable. Biochemistry 2000;39:7236-7244.
269. Chen H, Bernstein BW, Bamberg JR. Regulating actin-filament dynamics in vivo. Trends Biochem Sci 2000;25:19-23.
270. Chicurel ME, Singer RH, Meyer CJ, Ingber DE. Integrin binding and mechanical tension induce movement of mRNA and ribosomes to focal adhesions. Nature 1998;392:730-733.
271. Cmarik JL, Herschman H, Colburn NH. Preferential primary-response gene expression in promotion-resistant versus promotion-sensitive JB6 cells. Mol Carcinog 1994;11:115-124.
272. Cmarik JL, Hegamyer G, Gerrard B, Dean M, Colburn NH. cDNA cloning and mapping of mouse pleckstrin (Plek), a gene upregulated in transformation-resistant cells. Genomics 2000;66:204-212.
273. Goldstein LS. Molecular motors: From one motor many tails to one motor many tales. Trends Cell Biol 2001;11:477-482.
274. Walsh IK, Keane PF, Ishak LM, Flessland KA. The BTA stat test: A tumor marker for the detection of upper tract transitional cell carcinoma. Urology 2001;58:532-535.
275. Burk RF, Hill KE. Selenoprotein P. A selenium-rich extra-cellular glycoprotein. J Nutr 1994;124:1891-1897.
276. Takeuchi T, Kuro-o M, Miyazawa H, Ohtsuki Y, Yamamoto H. Transgenic expression of a novel thymic epithelial cell antigen stimulates abberant development of thymocytes. J Immunol 1997;159:726-733.
277. Patarca R, Freeman GJ, Schwartz J, et al. rpt-1, an intracellular protein from helper/inducer T cells that regulates gene expression of interleukin 2 receptor and human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1988;85:2733-2737.